Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus
Clinical trial NCT02229929 · COMPLETED
Trial details
- NCT number
- NCT02229929
- Sponsor
- Cara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-07-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.